Literature DB >> 29052596

t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma.

Anna Caliò1, Matteo Brunelli1, Diego Segala2, Serena Pedron1, Regina Tardanico3, Andrea Remo4, Stefano Gobbo2, Emanuela Meneghelli5, Claudio Doglioni6, Ondrej Hes7, Claudia Zampini1, Pedram Argani8, Guido Martignoni1,2.   

Abstract

Renal cell carcinomas with t(6;11) chromosome translocation involving the TFEB gene are indolent neoplasms which often occur in young patients. In this study, we report seven cases of renal cell carcinoma with TFEB rearrangement, two of whom had histologically proven metastasis. Patients (4F, 3M) ranged in age from 19 to 55 years (mean 37). One patient developed paratracheal and pleural metastases 24 months after surgery and died of disease after 46 months; another one recurred with neoplastic nodules in the perinephric fat and pelvic soft tissue. Histologically, either cytological or architectural appearance was peculiar in each case whereas one tumor displayed the typical biphasic morphology. By immunohistochemistry, all tumors labelled for cathepsin K, Melan-A and CD68 (KP1 clone). HMB45 and PAX8 staining were detected in six of seven tumors. All tumors were negative for CD68 (PG-M1 clone), CKAE1-AE3, CK7, CAIX, and AMACR. Seven pure epithelioid PEComa/epithelioid angiomyolipomas, used as control, were positive for cathepsin K, melanocytic markers, and CD68 (PG-M1 and KP1) and negative for PAX8. Fluorescence in situ hybridization results showed the presence of TFEB gene translocation in all t(6;11) renal cell carcinomas with a high frequency of split TFEB fluorescent signals (mean 74%). In the primary and metastatic samples of the two aggressive tumors, increased gene copy number was observed (3-5 fluorescent signals per neoplastic nuclei) with a concomitant increased number of CEP6. Review of the literature revealed older age and larger tumor size as correlating with aggressive behavior in these neoplasms. In conclusion, we present the clinical, morphological and molecular features of seven t(6;11) renal cell carcinomas, two with histologically demonstrated metastasis. We report the high frequency of split signals by FISH in tumors with t(6;11) chromosomal rearrangement and the occurrence of TFEB gene copy number gains in the aggressive cases, analyzing either the primary or metastatic tumor. Finally, we demonstrate the usefulness of CD68 (PG-M1) immunohistochemical staining in distinguishing t(6;11) renal cell carcinoma from pure epithelioid PEComa/epithelioid angiomyolipoma.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29052596     DOI: 10.1038/modpathol.2017.144

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  35 in total

1.  Translocation carcinomas of the kidney after chemotherapy in childhood.

Authors:  Pedram Argani; Marick Laé; Edgar T Ballard; Mahul Amin; Carlos Manivel; Brian Hutchinson; Victor E Reuter; Marc Ladanyi
Journal:  J Clin Oncol       Date:  2006-04-01       Impact factor: 44.544

2.  Sirolimus and temsirolimus for epithelioid angiomyolipoma.

Authors:  Nicholas Wolff; Wareef Kabbani; Thomas Bradley; Ganesh Raj; Lori Watumull; James Brugarolas
Journal:  J Clin Oncol       Date:  2010-01-04       Impact factor: 44.544

3.  Renal carcinoma with (6;11)(p21;q12) translocation: report of an adult case.

Authors:  Akira Ishihara; Yasuhiro Yamashita; Hiroki Takamori; Naoto Kuroda
Journal:  Pathol Int       Date:  2011-08-07       Impact factor: 2.534

4.  A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases.

Authors:  Fredrik Petersson; Tomáš Vaněček; Michal Michal; Guido Martignoni; Matteo Brunelli; Zbyněk Halbhuber; Dominic Spagnolo; Naoto Kuroda; Ximing Yang; Isabel Alvarado Cabrero; Milan Hora; Jindřich Branžovský; Sandra Trivunic; Denisa Kacerovská; Petr Steiner; Ondřej Hes
Journal:  Hum Pathol       Date:  2011-11-03       Impact factor: 3.466

5.  TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.

Authors:  Sounak Gupta; Sarah H Johnson; George Vasmatzis; Binu Porath; Jeannette G Rustin; Priya Rao; Brian A Costello; Bradley C Leibovich; R Houston Thompson; John C Cheville; William R Sukov
Journal:  Mod Pathol       Date:  2017-03-24       Impact factor: 7.842

Review 6.  Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature.

Authors:  Kvetoslava Peckova; Tomas Vanecek; Petr Martinek; Dominic Spagnolo; Naoto Kuroda; Matteo Brunelli; Semir Vranic; Slavisa Djuricic; Pavla Rotterova; Ondrej Daum; Bohuslava Kokoskova; Pavla Vesela; Kristyna Pivovarcikova; Kevin Bauleth; Magdalena Dubova; Kristyna Kalusova; Milan Hora; Michal Michal; Ondrej Hes
Journal:  Ann Diagn Pathol       Date:  2014-10-13       Impact factor: 2.090

Review 7.  Translocation carcinomas of the kidney.

Authors:  Pedram Argani; Marc Ladanyi
Journal:  Clin Lab Med       Date:  2005-06       Impact factor: 1.935

8.  Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum.

Authors:  Pedram Argani; Raluca Yonescu; Laura Morsberger; Kerry Morris; George J Netto; Nathan Smith; Nilda Gonzalez; Peter B Illei; Marc Ladanyi; Constance A Griffin
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

9.  A distinctive translocation carcinoma of the kidney ["rosette-like forming," t(6;11), HMB45-positive renal tumor].

Authors:  Milan Hora; Ondrej Hes; Tomás Urge; Viktor Eret; Jirí Klecka; Michal Michal
Journal:  Int Urol Nephrol       Date:  2008-11-08       Impact factor: 2.370

10.  Renal cell carcinoma with t(6:11) (p21;q12). A case report highlighting distinctive immunohistologic features of this rare tumor.

Authors:  Sarabjeet Kaur Arneja; Neeraj Gujar
Journal:  Int J Surg Case Rep       Date:  2014-12-23
View more
  9 in total

Review 1.  MiT family translocation renal cell carcinomas: A 15th anniversary update.

Authors:  Jatin S Gandhi; Faizan Malik; Mahul B Amin; Pedram Argani; Armita Bahrami
Journal:  Histol Histopathol       Date:  2019-09-06       Impact factor: 2.303

2.  Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung.

Authors:  Anna Caliò; Maria Cecilia Mengoli; Alberto Cavazza; Giulio Rossi; Claudio Ghimenton; Matteo Brunelli; Maurizio Pea; Marco Chilosi; Lisa Marcolini; Guido Martignoni
Journal:  Virchows Arch       Date:  2018-03-07       Impact factor: 4.064

3.  TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.

Authors:  Sounak Gupta; Pedram Argani; Achim A Jungbluth; Ying-Bei Chen; Satish K Tickoo; Samson W Fine; Anuradha Gopalan; Hikmat A Al-Ahmadie; Sahussapont J Sirintrapun; Alejandro Sanchez; Abraham Ari Hakimi; Tiffany Mcfarlane; Paulo A Salazar; Sean R Williamson; Stephanie L Skala; Rohit Mehra; Ondrej Hes; Cristina R Antonescu; Marc Ladanyi; Maria E Arcila; Victor E Reuter
Journal:  Am J Surg Pathol       Date:  2019-11       Impact factor: 6.394

Review 4.  A review of neoplasms with MITF/MiT family translocations.

Authors:  Shuanzeng Wei; Joseph R Testa; Pedram Argani
Journal:  Histol Histopathol       Date:  2022-02-02       Impact factor: 2.303

5.  NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.

Authors:  Jianming Pei; Harry Cooper; Douglas B Flieder; Jacqueline N Talarchek; Tahseen Al-Saleem; Robert G Uzzo; Essel Dulaimi; Arthur S Patchefsky; Joseph R Testa; Shuanzeng Wei
Journal:  Mod Pathol       Date:  2019-01-08       Impact factor: 7.842

Review 6.  Microphthalmia family of transcription factors associated renal cell carcinoma.

Authors:  Ling Xie; Yifen Zhang; Chin-Lee Wu
Journal:  Asian J Urol       Date:  2019-05-03

Review 7.  Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai.

Authors:  Anna Caliò; Matteo Brunelli; Stefano Marletta; Giuseppe Zamboni; Franco Bonetti; Maurizio Pea; Guido Martignoni
Journal:  Pathologica       Date:  2021-10

8.  t(6; 11) renal cell carcinoma. A case report successfully diagnosed by using fluorescence in situ hybridization.

Authors:  Hidekazu Nishizawa; Masaya Baba; Mitsuko Furuya; Ikuma Kato; Ryoma Kurahashi; Yumi Honda; Yoshiki Mikami; Yoji Nagashima; Masatoshi Eto; Tomomi Kamba
Journal:  IJU Case Rep       Date:  2021-08-12

Review 9.  Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors.

Authors:  Anna Caliò; Matteo Brunelli; Stefano Gobbo; Pedram Argani; Enrico Munari; George Netto; Guido Martignoni
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.